The association of PON1 rs662 with atherogenic dyslipidaemia (P = 0.018) persisted in multiple regression analysis including age (P = 0.974), male gender (P = 0.641), diabetic nephropathy (P = 0.327), and lipid-modifying treatment (P = 0.002). This evidence concerns the gene PON1 and diabetic kidney disease.